AI is playing a big role in oncology research right now.
BostonGene is working with Ottimo Pharma to accelerate development of a new immuno oncology therapy using advanced analytics and multiomic data.
More details here:
https://bostongene.com/news-an....d-publications/news/
AI Powered Oncology Development Initiative
BostonGene has entered a strategic collaboration with AstraZeneca focused on integrating artificial intelligence into oncology research. The initiative supports foundation model driven analytics to enhance drug discovery and clinical development strategies.
As healthcare becomes increasingly data driven, advanced AI systems are essential for accelerating innovation and improving therapeutic outcomes in cancer treatment.
Explore the full industry announcement: https://bostongene.com/news-an....d-publications/news/
Independent Study Supports AI in HER2 Scoring
A recent independent multi vendor study validated an AI based method for precision HER2 scoring in breast cancer diagnostics. Results showed strong alignment with expert pathology evaluation, supporting improved consistency in biomarker assessment.
Read the complete article here https://bostongene.com/news-an....d-publications/news/
Immune and Fibroblast Profiles in Breast Cancer
Understanding the tumor microenvironment is key in cancer biology. A recent research article explores how tumor-associated macrophages (TAMs) and cancer-associated fibroblasts (CAFs) differ between invasive lobular carcinoma (ILC) and no special type (NST) breast cancers. Using transcriptomic analysis the study examines patterns of immune and stromal cell composition across tumor types, providing insights for research on tumor behavior and immune interactions.
Read the full research article at https://bostongene.com/news-an....d-publications/publi
